Trial intelligence / Profile preview

Intravenous acetaminophen versus intravenous morphine for pain reduction in limb trauma patients

IRCT20190618043934N26Phase 3Completed

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in acute pain comparing Intravenous morphine with Intravenous acetaminophen (2 arms). Primary endpoint: Pain level at baseline and after treatment at 30 minutes. Started Jul 2024; status: completed.

02

Drugs

acetaminophenmorphine
03

Conditions

acute pain

Beyond the preview

Go deeper on IRCT20190618043934N26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190618043934N26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call